已收盤 12-24 16:00:00 美东时间
-0.040
-0.04%
今日重点评级关注:杰富瑞:维持ImmunityBio Inc Ordinary Shares"买入"评级,目标价从8美元升至9美元;B. Riley证券:维持WAVE Life Sciences"买入"评级,目标价从19美元升至37美元
12-15 15:30
UBS analyst George Eadie maintains Warrior Met Coal (NYSE:HCC) with a Neutral and raises the price target from $80 to $86.
12-13 05:42
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从4美元升至9美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从32美元升至38美元
11-25 10:27
UBS analyst George Eadie maintains Warrior Met Coal (NYSE:HCC) with a Neutral and raises the price target from $75 to $80.
11-24 22:56
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价;Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
11-07 10:14
U.S. stocks were lower, with the Dow Jones index falling more than 400 points o...
11-07 01:42
Warrior Met Coal shares are trading higher after the company beat Q3 earnings a...
11-06 06:08
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
国元国际发布研报称,和誉-B(02256)是小分子创新药龙头。预计2025-27年收入分别为人民币6.50亿、6.80亿、7.30亿元,净利润分别为0.9...
10-29 13:48
(来源:新华日报) □ 惠楷轩 凯信远达首款自主生产药品“马法兰®”(注射用盐酸美法仑)正式获批上市并实现供货;麦默真空自主研发的国产首款DSA(数字减影血...
10-29 05:00